ROSALINDA HEYDARIAN: Open Payments
NPI 1255661237 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$191 in 8 payments from 4 companies in 2025. Trend: 2023 $370 · 2024 $236 · 2025 $191
Food & beverage: $191
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $73 |
| Gilead Sciences, Inc. | 2 | $49 |
| Janssen Biotech, Inc. | 2 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
Products named: OPDIVO, Trodelvy, RYBREVANT, TALVEY, Nubeqa.
Industry payments across TX — which companies pay providers there.
